Atomoxetine

What is Atomoxetine?

Atomoxetine is a selective norepinephrine reuptake inhibitor (SNRI) medication primarily used to treat attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. Unlike stimulant medications commonly used for ADHD, atomoxetine is classified as a non-stimulant treatment option. It was the first non-stimulant medication approved by the FDA specifically for ADHD treatment.

Uses

Atomoxetine has several documented therapeutic applications:

• ADHD in children and adolescents: Primary treatment for reducing hyperactivity, impulsivity, and inattention symptoms in patients aged 6 years and older
• Adult ADHD: Treatment of attention deficit hyperactivity disorder symptoms that continue into adulthood
• Alternative to stimulants: Used when stimulant medications are not suitable due to substance abuse concerns, side effects, or patient preference
• Comorbid conditions: May be preferred in patients with ADHD who also have anxiety disorders or tic disorders
• Off-label uses: Sometimes prescribed for certain cases of depression or anxiety, though this is not an FDA-approved indication

How it works

Atomoxetine works by blocking the reuptake of norepinephrine, a neurotransmitter that plays a crucial role in attention, alertness, and executive function. By preventing nerve cells from reabsorbing norepinephrine too quickly, the medication increases the availability of this neurotransmitter in specific brain regions associated with attention and impulse control. This mechanism helps improve focus, reduce hyperactivity, and enhance cognitive control without the stimulating effects seen with amphetamine-based ADHD medications.

Side effects

Common side effects include:

Submit Your Paper

• Decreased appetite and weight loss
• Nausea and stomach upset
• Fatigue and drowsiness
• Dizziness
• Mood changes or irritability
• Constipation
• Dry mouth
• Sleep problems (insomnia or excessive sleepiness)

Serious side effects to watch for:

• Suicidal thoughts or behavior, especially in children and young adults
• Severe liver problems (jaundice, dark urine, severe fatigue)
• Heart rhythm abnormalities or chest pain
• Severe allergic reactions
• Significant blood pressure or heart rate changes

Warnings and precautions

• Suicide risk: FDA black box warning for increased risk of suicidal thoughts in children and adolescents; patients require close monitoring, especially when starting treatment
• Cardiovascular conditions: Should be used with caution in patients with heart problems, high blood pressure, or irregular heartbeat; baseline cardiovascular assessment recommended
• Liver function: Can cause severe liver injury in rare cases; patients should be monitored for signs of liver problems and discontinue if jaundice occurs
• Pregnancy considerations: Pregnancy category C; potential risks to fetus should be weighed against benefits; effects on breastfeeding infants are not well established
• Mental health conditions: May worsen symptoms of bipolar disorder, depression, or psychosis; careful screening and monitoring required

Interactions

• MAO inhibitors: Dangerous interaction that can cause severe blood pressure changes; must avoid concurrent use and allow washout periods
• Strong CYP2D6 inhibitors (fluoxetine, paroxetine): Increase atomoxetine levels significantly, requiring dose adjustments
• Pressor agents (albuterol, pseudoephedrine): May increase cardiovascular side effects when combined
• Blood pressure medications: Effects may be altered; blood pressure monitoring recommended
• QT-prolonging medications: Potential for additive effects on heart rhythm
• Warfarin and anticoagulants: May affect bleeding risk; monitoring recommended
• Alcohol: May increase drowsiness and impair judgment; concurrent use not recommended
• St. John’s Wort: May reduce atomoxetine effectiveness through enzyme induction

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosing starts at 40 mg once daily, with gradual increases based on response and tolerability. The usual target dose ranges from 80-100 mg per day, which may be taken as a single daily dose or divided into two doses. Maximum recommended dose is 100 mg per day for most adults. In patients who are poor metabolizers of CYP2D6 or taking strong CYP2D6 inhibitors, lower doses are typically required. Dosage adjustments should always be made gradually over several weeks, and individual dosing must be determined by a healthcare provider based on patient response, body weight, and other clinical factors.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).